Dorward, J., Sookrajh, Y., Lessells, R., Bulo, E., Bodley, N., Singh, L., . . . Garrett, N. (2024). Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy. Journal of acquired immune deficiency syndromes (1999), 95(5), . doi:10.1097/QAI.0000000000003385
Chicago ZitierstilDorward, Jienchi, et al. "Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy." Journal of Acquired Immune Deficiency Syndromes (1999) 95, no. 5 (2024).
MLA ZitierstilDorward, Jienchi, et al. "Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy." Journal of Acquired Immune Deficiency Syndromes (1999) 95.5 (2024).